146 related articles for article (PubMed ID: 10668466)
21. Calcium binding of transglutaminases: a 43Ca NMR study combined with surface polarity analysis.
Ambrus A; Bányai I; Weiss MS; Hilgenfeld R; Keresztessy Z; Muszbek L; Fésüs L
J Biomol Struct Dyn; 2001 Aug; 19(1):59-74. PubMed ID: 11565852
[TBL] [Abstract][Full Text] [Related]
22. Novel site-specific immobilization of a functional protein using a preferred substrate sequence for transglutaminase 2.
Sugimura Y; Ueda H; Maki M; Hitomi K
J Biotechnol; 2007 Aug; 131(2):121-7. PubMed ID: 17658645
[TBL] [Abstract][Full Text] [Related]
23. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
[TBL] [Abstract][Full Text] [Related]
24. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
Rosenthal AK; Mosesson MW; Gohr CM; Masuda I; Heinkel D; Seibenlist KR
Thromb Haemost; 2004 Mar; 91(3):558-68. PubMed ID: 14983233
[TBL] [Abstract][Full Text] [Related]
25. Roles of transglutaminases in cardiac and vascular diseases.
Sane DC; Kontos JL; Greenberg CS
Front Biosci; 2007 Jan; 12():2530-45. PubMed ID: 17127261
[TBL] [Abstract][Full Text] [Related]
26. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
28. On the early events of the calcium-induced activation of coagulation factor XIII-A
Fekete A; Komáromi I; Mucs D
J Biomol Struct Dyn; 2020 Jan; 38(1):152-167. PubMed ID: 30707083
[TBL] [Abstract][Full Text] [Related]
29. Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.
Souri M; Koseki-Kuno S; Takeda N; Yamakawa M; Takeishi Y; Degen JL; Ichinose A
Thromb Haemost; 2008 Feb; 99(2):401-8. PubMed ID: 18278192
[TBL] [Abstract][Full Text] [Related]
30. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
[TBL] [Abstract][Full Text] [Related]
31. Transglutaminase II: a new class of GTP-binding protein with new biological functions.
Im MJ; Russell MA; Feng JF
Cell Signal; 1997 Nov; 9(7):477-82. PubMed ID: 9419811
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides.
Watanabe K; Tsunoda K; Itoh M; Fukui M; Mori H; Hitomi K
Amino Acids; 2013 Jan; 44(1):209-14. PubMed ID: 22045386
[TBL] [Abstract][Full Text] [Related]
33. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
[TBL] [Abstract][Full Text] [Related]
34. Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
Cordell PA; Newell LM; Standeven KF; Adamson PJ; Simpson KR; Smith KA; Jackson CL; Grant PJ; Pease RJ
Matrix Biol; 2015 Apr; 43():85-96. PubMed ID: 25680676
[TBL] [Abstract][Full Text] [Related]
35. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues.
Greenberg CS; Birckbichler PJ; Rice RH
FASEB J; 1991 Dec; 5(15):3071-7. PubMed ID: 1683845
[TBL] [Abstract][Full Text] [Related]
36. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
[TBL] [Abstract][Full Text] [Related]
37. The 55 kDa tissue transglutaminase cross-linking active isoform TG induces cell death.
Fraij BM
Mol Carcinog; 2015 Sep; 54(9):720-9. PubMed ID: 24464646
[TBL] [Abstract][Full Text] [Related]
38. [Blood coagulation factor XIII: activation, substrates and structure of a transglutaminase].
Sicker T; Hilgenfeld R
Hamostaseologie; 2002 Feb; 22(1):20-7. PubMed ID: 12193981
[TBL] [Abstract][Full Text] [Related]
39. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
Fontana A; Spolaore B; Mero A; Veronese FM
Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminases in mineralized tissues.
Nurminskaya M; Kaartinen MT
Front Biosci; 2006 May; 11():1591-606. PubMed ID: 16368540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
